Capital Flow Monitor · Sponsors · CIK 1792522
MindImmune Therapeutics, Inc.
130 FLAGG ROAD, KINGSTON, RI, 02881 · 401-225-4612
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$17.0M
Sold
$15.2M
% sold
89.4%
Investors
15
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-05 | D/A ·current | 506(b) | $17.0M | $15.2M | 89.4% | 15 | EDGAR ↗ |
| 2025-12-05 | D | 506(b) | $12.0M | $10.2M | 85.0% | 14 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Isaac Stoner — Executive Officer / Director, Kingston, RI
- Bradley Margus — Director, Kingston, RI
- Christopher O'Donnell — Director, Kingston, RI
- Reetika Bhardwaj — Director, Kingston, RI
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.